Does the use of proton pump inhibitors in children affect ventricular repolarisation parameters?
Related Experiment Video
Updated: Sep 25, 2025

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Onur Tasci1, Ezgi Kiran Tasci2
1Department of Pediatric Cardiology, Sivas Numune Hospital, Sivas, Turkey.
Insights
Proton pump inhibitors did not significantly alter ventricular repolarization parameters in children with dyspepsia. This study found no changes in corrected QT interval or other ECG measures, suggesting safety in this population.
Area of Science:
- Cardiology
- Pediatric Gastroenterology
- Clinical Pharmacology
Background:
- Proton pump inhibitors (PPIs) are common dyspepsia treatments.
- Their impact on cardiac ion channels and ventricular repolarization is known.
- Understanding PPI effects on pediatric cardiac electrophysiology is crucial.
Purpose of the Study:
- To assess changes in electrocardiogram (ECG) ventricular repolarization parameters before and after PPI treatment in children with dyspepsia.
- To evaluate the safety of PPIs regarding cardiac electrical activity in pediatric patients.
Main Methods:
- A study involving 69 pediatric patients (mean age 13.16 years) with chronic dyspepsia symptoms.
- ECG parameters including QT interval, corrected QT (QTc), and Tp-e were measured initially and after 1 month of PPI treatment.
- Electrolyte levels were monitored before and after treatment.
Main Results:
- No statistically significant differences were observed in QTc, Tp-e duration, or Tp-e/QT ratio post-PPI treatment.
- Patient electrolyte levels remained within normal ranges throughout the study.
- No ventricular arrhythmias were detected during the follow-up period.
Conclusions:
- PPI treatment did not significantly prolong QTc duration or affect other ventricular repolarization parameters in children with dyspepsia.
- While this study suggests PPIs are safe regarding ventricular repolarization in this group, larger studies and longer follow-up are warranted.
- Caution is advised for drugs affecting QT interval, with potential need for serial ECG monitoring.
Abstract:
Proton pump inhibitors are widely used agents in the treatment of dyspepsia, and their effects on ventricular repolarisation through ion channels are well-known. Our aim is to evaluate the change in ventricular repolarisation parameters on electrocardiogram before and after proton pump inhibitor treatment. This study included 69 patients who had symptoms such as burning stomach pain, bloating, nausea, and heartburn for at least 3 months. Electrolyte levels of the patients were measured before and after treatment, and 12-lead electrocardiograms were taken at the initial and 1st month follow-up visit. Heart rate, QT interval, corrected QT (QTc), QT dispersion (QTd), QTc dispersion (QTcd), Tp-e measurements, and Tp-e/QT ratio were calculated and compared. Thirty-nine of the patients were girls, 30 were boys, and the mean age was 13.16 ± 3.02 years. Electrolyte levels of the patients before and after treatment were within the normal range. There was no statistically significant difference in the QTc, the Tp-e duration, or the Tp-e/QT ratio of the patients before and after treatment. We did not find a significant prolongation in the QTc duration or any other ventricular repolarisation parameters after proton pump inhibitor treatment in children with dyspepsia. We did not observe ventricular arrhythmia in our patients during follow-up. However, different results might be obtained with a larger sample and a longer follow-up period. These patients may have an increased risk of developing ventricular arrhythmias. Therefore, precaution should be taken when using drugs that prolong the QT period, and follow-up with serial electrocardiograms should be planned.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

